Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 4, 2003, Pages 1598-1607

  Jiang, Hui Rong ^a   Muckersie, Elizabeth ^a   Robertson, Marie ^a   Forrester, John V ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; T LYMPHOCYTE; TH1 CELL; UVEORETINITIS;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW CELLS; CYTOKINES; DENDRITIC CELLS; EYE PROTEINS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY, ADOPTIVE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MICE; PEPTIDE FRAGMENTS; RETINITIS; RETINOL-BINDING PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES; UVEITIS;

EID: 0037378686     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0427     Document Type: Article

References (50)

1. Forrester JV. Duke-Elder lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 1992;6:433-446.
2. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. Prog Retinal Res. 1986;75-109.
3. Caspi RR, Roberge FG, Mcallister CG, et al. T-cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986;136:928-933.
4. Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990;9:75-84.
5. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci. 1999;40:3177-3185.
6. Dick AD, McMenamin PG, Korner H, et al. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol. 1996;26:1018-1025.
7. Caspi RR. Immune mechanisms in uveitis. Springer Semin Immunopathol. 1999;21:113-124.
8. Caspi RR, Sun B, Agarwal RK, et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye 1997;11:209-212.
9. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol. 1997;178:69-78.
10. Prendergast RA, Iliff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1998;39:754-762.
11. Link H, Huang YM, Xiao BG. Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis. J Neuroimmunol. 1999;100:102-110.
12. Kozhich AT, Caspi RR, Berzofsky JA, Gery I. Immunogenicity and immunopathogenicity of an autoimmune epitope are potentiated by increasing MHC binding through residue substitution. J Immunol. 1997;158:4145-4151.
13. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and mannose receptor to concentrate macromolecules in the major histocompatibility complex class-II compartment: down regulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400.
14. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 1997;388:782-787.
15. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252,
16. Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost functionally superior CD8(+) T-cell without foreign helper epitopes. J Clin Invest. 2000;105:R9-R14.
17. Dhodapkar MV, Steinman RM, Sapp M, et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest. 1999;104:173-180.
18. Thurner B, Haendle I, Roder C, et al. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med. 1999;190:1669-1678.
19. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med. 1997;185:541-550.
20. Bonham CA, Lu L, Banas RA, et al. TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transpl Immunol. 1996;4:186-191.
21. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte macrophage colony-stimulating factor. J Exp Med. 1992;176:1693-1702.
22. Stockinger B, Zal T, Zal A, Gray D. B cells solicit their own help from T cells. J Exp Med, 1996;183:891-899.
23. Liversidge J, Dick A, Daniels G, Dawson R. Induction or suppression of a B cell-specific response to self antigen in vivo is dependent upon dendritic cell activation via the TNF-alpha receptor at the time of antigen uptake. Eur J Immunol. 2000;30:2268-2280.
24. Laliotou B, Duncan L, Dick AD. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen. J Autoimmun. 1999;12:145-155.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem. 1987;162:156-159.
26. Chan CC, Caspi RR, Ni M, et al. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990;3:247-255.
27. Lutz MB, Suri RM, Ogilvie ALJ, et al. Maturation-resistant stably immature dendritic cells induce T cell unresponsiveness in vitro and prolong allograft survival in vivo (Abstract). J Invest Dermatol. 1999;113:261.
28. Jiang HR, Taylor N, Duncan L, Dick A, Forrester JV. Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction. Br J Ophthalmol. 2001;85:739-744.
29. Jiang HR, Wei X, Niedbala W, Lumsden L, Liew FY, Forrester JV. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci. 2001;42:177-182.
30. Labeur MS, Roters B, Pers B, et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol. 1999;162:168-175.
31. Lu L, McCaslin D, Starzl TE, Thomson AW. Bone marrow-derived dendritic cell progenitors (NLDC 145(+), MHC class II+, B7-1(dim), B7-2(-)) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation. 1995;60:1539-1545.
32. Antonysamy MA, Fanslow WC, Fu FM, et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol. 1999;162:577-584.
33. DeSmedt T, Pajak B, Muraille E, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med. 1996;184:1413-1424.
34. De Smedt T, Pajak B, Klaus GGB, et al. Cutting edge: Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol. 1998;161:4476-4479.
35. McRae BL, Nagai T, Semnani RT, van Seventer JM, van Seventer GA. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood. 2000;96:210-217.
36. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
37. Masurier C, Pioche-Durieu C, Colombo BM, et al. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy. Immunology. 1999;96:569-577.
38. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 2000;30:1813-1822.
39. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001;193:233-238.
40. Zitvogel L, Mayordomo JI, Tiandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med. 1996;183:87-97.
41. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192:1213-1222.
42. Xiao BG, Huang YM, Yang JS, Xu LY, Link H. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin Exp Immunol. 2001;125:300-309.
43. Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today. 1999;20:442-446.
44. Groux H, OGarra A, Bigler M, et al. A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-742.
45. Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes. 1999;48:2300-2308.
46. Egwuagu CE, Sztein J, Mahdi RM, et al. IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol. 1999;162:510-517.
47. Menges M, Rossner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med. 2002;195:15-21.
48. Lutz MB, Suri RM, Niimi M, et al. Maturation-resistant immature dendritic cells generated with low doses of GM-CSF prolong heart allograft survival in vivo (Abstract). J Invest Dermatol. 2000;114:216.
49. Streilein, JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 1997;158:3557-3560.
50. Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol. 2001;166:42-50.